CNSX:CSI Chemesis International (CSI) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free CSI Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume63,715 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Chemesis International alerts: Email Address Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! About Chemesis InternationalChemesis International Inc. focuses on acquiring, identifying, acquiring, and evaluating interests in mineral properties in North America. The company holds an option to acquire a 100% interest in the Rose Property located in the Kamloops Mining Division in British Columbia. Chemesis International Inc. is headquartered in Vancouver, Canada.Read More Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! CSI Stock News HeadlinesApril 2, 2024 | msn.comCSI: Seplat Says Community, People Empowerment Critical to Energy Sector StabilityMarch 10, 2024 | msn.comCSI in space: Analyzing bloodstain patterns in microgravityApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.February 27, 2024 | msn.comUAE: Ajman Consumer Sentiment Index rises in 2023, exceeding global averageJanuary 9, 2024 | forbes.comCSI CompaniesNovember 21, 2023 | investing.comCSI Hong Kong Dividend (HKCSHKDIV)September 11, 2023 | businesswire.comCSI Recognized as a Top Fintech Provider by IDC Financial Insights for 12th Consecutive YearAugust 21, 2023 | hulldailymail.co.ukHull street cordoned off and tent erected as police and CSI respond to incidentApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.August 12, 2023 | investing.comCSI 1000 (CSI1000I)February 26, 2023 | benzinga.comXLCS Partners advises Component Sourcing International in sale to CPCFebruary 16, 2023 | usnews.comCSI High School for International StudiesFebruary 6, 2023 | finance.yahoo.comCSI 300 Index (000300.SS)November 25, 2022 | benzinga.comCSE Bulletin: Change of Business - Chemesis International Inc./Refined Metals CorpJuly 21, 2022 | finance.yahoo.comChemesis Announces Change in ManagementSeptember 2, 2021 | sg.finance.yahoo.comMFDA Hearing Panel issues Reasons for Decision in the matter of Tyler DavidsonAugust 31, 2021 | finance.yahoo.comChemesis International Inc. Announces Director ResignationAugust 8, 2021 | investing.comChemesis International Inc (CSI)August 5, 2021 | msn.comFrom Learning to Leading: CSI’s diesel technology programAugust 3, 2021 | benzinga.comSignature Bank of Arkansas Chooses CSI's NuPoint Core to Fuel Growth with Innovative, Integrated Bank TechnologyAugust 1, 2021 | msn.comJob Corps program at CSI entering second yearJuly 30, 2021 | benzinga.comUnusual Options Activity Insight: Xtrackers Harvest CSI 300 China A-Shares ETFJuly 30, 2021 | sfgate.comCSI Compressco: Q2 Earnings SnapshotJuly 30, 2021 | finance.yahoo.comCSI Compressco LP Announces Second Quarter 2021 ResultsJuly 28, 2021 | benzinga.comAnalyzing CSI Compressco's Ex-Dividend DateJuly 28, 2021 | markets.businessinsider.comMBA CSi Named Winner of USPS 2020 Supplier Excellence AwardJuly 28, 2021 | msn.comHope amid tragedy: CSI team searches for 'priceless' jewel for mourning husbandSee More Headlines Receive CSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemesis International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCNSX:CSI CUSIPN/A CIKN/A Webwww.chemesis.com Phone604-398-3378FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Amandeep Singh Parmar (Age 35)Chairman & Interim CEO Comp: $228.26kMr. Joshua Rosenberg (Age 45)Pres & Director Comp: $142.66kMr. Eli Seamus-Sweet Dusenbury C.A. (Age 39)CPA, CA, CPA, CFO & Corp. Sec. Comp: $114.13kMr. Terry WhiteSr. VP of OperationsDr. Joshua HartselChief Science OfficerMs. Vinnie PappanoVP of Sales & Category Management of CBDMr. Thomas J. Gingerich (Age 61)Controller More ExecutivesKey CompetitorsAbattis BioceuticalsCNSX:ATTAgraflora Organics InternationalCNSX:AGRAAmplify Alternative Harvest ETFCNSX:MJBio-Rad LaboratoriesCNSX:BIOBlueberries MedicalCNSX:BBMView All Competitors CSI Stock Analysis - Frequently Asked Questions How do I buy shares of Chemesis International? Shares of CSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:CSI) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemesis International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.